Stevanato Group S.p.A. (STVN)
21.77
0.19 (0.88%)
At close: Mar 20, 2025, 3:59 PM
21.21
-2.57%
After-hours: Mar 20, 2025, 08:00 PM EDT
Company Description
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare.
Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.
The company was founded in 1949 and is headquartered in Piombino Dese, Italy.
Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
Stevanato Group S.p.A.
| Country | IT |
| IPO Date | Jul 16, 2021 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 5,521 |
| CEO | Franco Stevanato |
Contact Details
Address: Via Molinella, 17 Piombino Dese, PD IT | |
| Website | https://www.stevanatogroup.com |
Stock Details
| Ticker Symbol | STVN |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001849853 |
| CUSIP Number | T9224W109 |
| ISIN Number | IT0005452658 |
| Employer ID | 00-0000000 |
| SIC Code | 3221 |
Key Executives
| Name | Position |
|---|---|
| Franco Stevanato | Chief Executive Officer & Executive Chairman |
| Marco Dal Lago | Chief Financial Officer |
| Lisa Miles | Chief Communication Officer & Senior Vice President of Investor Relations |
| Mauro Stocchi | Chief Business Officer |
| Paolo De Fabritiis | Chief HR Officer |
| Riccardo Butta | President of Americas |
| Ugo Gay | Chief Operations Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 14, 2025 | 6-K | Filing |
| Mar 06, 2025 | 20-F | Filing |
| Mar 06, 2025 | 6-K | Filing |
| Mar 06, 2025 | 6-K | Filing |
| Feb 10, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Jan 17, 2025 | 6-K | Filing |
| Jan 10, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Nov 14, 2024 | SCHEDULE 13G | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | 6-K | Filing |